Management indicated the pivotal and ASPIRE trials are "on track to complete dosing in the second quarter of 2026." The company expects to initiate BLA-enabling process performance qualification (PPQ) ...

Vincent Ma, MD, associate professor in the Department of Medicine at the University of Wisconsin School of Medicine and ...

This clinical-stage biopharma targets neurological and psychiatric disorders with a pipeline of novel therapeutics advancing through trials.

DYNAMIKA™ delivers SOC 2 Type II–certified, AI‑driven imaging workflows, giving pharma and biotech secure, compliant ...

Whole-blood transfusion has recently gained favor in the management of severe hemorrhage; however, data from large clinical trials evaluating its clinical effectiveness and safety are lacking. We ...

Predictive analytics and real-time monitoring are improving clinical supply efficiencies, yet agentic AI may be the next frontier in supply chain management.

Felicia Pasadyn balances medical school and professional running, recently qualifying for the Olympic Marathon Trials while ...

VESALIUS-CV is a large (N=12 257), rigorously conducted, international, randomized, placebo-controlled trial conducted in patients at high cardiovascular risk but without prior myocardial infarction ...

Invivoscribe, a leader in precision medicine and measurable residual disease (MRD) testing, today announced the addition of the LeukoStrat® KMT2A + MRD Assay and Software to its industry-leading ...

Site-led, performance-driven SMO unites top independent research sites within a harmonized, enterprise-grade organization RENTON, WA, UNITED STATES, January 13, 2026 ...